A market-facing survey report published by NutraIngredients on 29 July 2026 found that cognitive symptoms in perimenopause were causing more concern than physical changes. That puts brain fog, forgetfulness, reduced concentration and mental fatigue ahead of the hot flushes and night sweats that still dominate public shorthand for the transition.
The gap matters because UK health guidance already says perimenopause and menopause symptoms can hit relationships, social life, family life and work. The Menopause Charity describes brain fog as a very common symptom of perimenopause and menopause, saying it can feel like the brain is “cotton wool” and can make it hard to concentrate, retain information and function at work. Its brain fog page was last updated in October 2022 and was due for review in October 2025.
UCL has been putting harder numbers behind the same complaint. In an article dated 13 April 2026, its Faculty of Brain Sciences said brain fog affects two-thirds of women going through menopause and is still poorly understood. UCL’s CST-Meno project page goes further, saying cognitive symptoms are highly prevalent in the menopause transition, that many women fear early-onset dementia, and that one in 10 women permanently leaves work because of symptoms.
For the UK women’s health market, that is a clear signal that menopause messaging has moved beyond vasomotor relief. Product developers and retailers that frame offerings only around hot flush support risk missing the symptom cluster many women say matters most to their day-to-day functioning. NutraIngredients reported on 14 April 2026 that menopause supplement launches were becoming more symptom- and stage-specific, and on 22 July 2026 that Heights was targeting menopause brain health with an MRI study. ClinicalTrials.gov also lists a 12-week multi-vitamin/mineral supplementation study on perimenopause symptoms, cognition, sleep and psychological well-being, with the record published on 29 May 2026.
The care pathway implication is just as stark. Cognitive complaints in midlife are often written off as stress, poor sleep, ageing or overwork, yet the research landscape is treating them as a core perimenopause issue. Nature published a paper on 16 March 2026, titled Cognition and the menopause transition: cross-sectional ..., adding to evidence that self-reported cognitive symptoms can rise even when objective task performance remains largely intact. That distinction matters in consultations, where women may lead with worries about focus, memory and confidence rather than menstrual change.
It also reaches beyond symptom management into diagnosis and care-seeking. UCL called for a nationwide menopause education programme on 20 October 2025, saying more than three-quarters of women felt they were not well-informed enough about menopause, and in March 2026 it said Black women in the UK were entering menopause severely under informed, under supported and often dismissed by healthcare professionals. The survey result does not stand in for clinical evidence, but it does show where women are placing the burden of perimenopause now: on their ability to think, work and function, not just on what they can see.